Fig. 4
From: Risk of mortality associated with respiratory syncytial virus and influenza infection in adults
Kaplan-Meier survival curves of 312 adults hospitalized for influenza virus infection, who did not undergo oseltamivir therapy (red line, n = 65) and who did undergo oseltamivir therapy (blue line, n = 247). Twenty-day all-cause mortality rates among influenza patients treated with and without oseltamivir were 6.4% and 7.6%, respectively (P = 0.72)